941 filings
Page 7 of 48
SC 13G/A
AMAG
Amag Pharmaceuticals, Inc.
4 Feb 20
Beneficial ownership report (amended)
12:00am
SC 13G
GS
Goldman Sachs Group, Inc.
31 Jan 20
Amag Pharmaceuticals, Inc.
12:05pm
4
AMAG
Amag Pharmaceuticals, Inc.
28 Jan 20
AMAG PHARMACEUTICALS / Steven Boyd ownership change
4:48pm
4
Armistice Capital, LLC
13 Jan 20
AMAG PHARMACEUTICALS / Steven Boyd ownership change
5:47pm
8-K
AMAG
Amag Pharmaceuticals, Inc.
9 Jan 20
AMAG Pharmaceuticals Announces Leadership Transition, Results of Strategic Review
7:15am
3
Kelly Schick
3 Jan 20
AMAG PHARMACEUTICALS / Kelly Schick ownership change
9:17am
8-K
AMAG
Amag Pharmaceuticals, Inc.
3 Dec 19
Departure of Directors or Certain Officers
4:13pm
10-Q
2019 Q3
AMAG
Amag Pharmaceuticals, Inc.
Quarterly report
1 Nov 19
5:15pm
8-K
AMAG
Amag Pharmaceuticals, Inc.
1 Nov 19
Amag Pharmaceuticals Announces Third Quarter 2019 Financial Results
7:03am
8-K
AMAG
Amag Pharmaceuticals, Inc.
30 Oct 19
Amag Reports on Fda Advisory Committee Meeting for Company to Comment During Third Quarter Financial Results Conference Call on
7:46am
SC 13G
Camber Capital Management LP
15 Oct 19
Amag Pharmaceuticals, Inc.
9:51am
4
Johnson David Edward
10 Oct 19
AMAG PHARMACEUTICALS / DAVID EDWARD JOHNSON ownership change
6:11pm
4
Paul R. Fonteyne
10 Oct 19
AMAG PHARMACEUTICALS / PAUL R. FONTEYNE ownership change
5:04pm
3
Paul R. Fonteyne
10 Oct 19
AMAG PHARMACEUTICALS / PAUL R. FONTEYNE ownership change
5:00pm
SC 13D/A
Caligan Partners LP
10 Oct 19
Amag Pharmaceuticals, Inc.
4:32pm
8-K
AMAG
Amag Pharmaceuticals, Inc.
8 Oct 19
AMAG Pharmaceuticals Announces Settlement Agreement with Caligan Partners LP
10:20am
DEFA14A
AMAG
Amag Pharmaceuticals, Inc.
8 Oct 19
Additional proxy soliciting materials
9:32am
DEFA14A
AMAG
Amag Pharmaceuticals, Inc.
4 Oct 19
Additional proxy soliciting materials
4:15pm
DFRN14A
Caligan Partners LP
26 Sep 19
Revised proxy by non-management
5:00pm
DFAN14A
Caligan Partners LP
26 Sep 19
Additional proxy materials by non-management
8:55am